ArticleJournal of enzyme inhibition and medicinal chemistry2023

Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells.

Aide Negri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.